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$ 1. INTROD~CTION 
13'Cs nlust be considered as a potentially hazardous radionuclide and a 
considerable amount of bo fk~  has been done aiming a t  the enhancement 
OS 137Cs-excretion. Slightly higher urinary excretion rates were observed 
by Kurlandskaya (1957) arid Ogawa, &fachida, Suzuki and Shibata (1938) 
following the administration of stable Cs-salts; however, 3loskalev (1961 b) 
fttiled to confirm this finding. The excretion of 13'Cs in rats was enhanced 
by increasing the potassium content of the diet (Richmond and Furchner 
1961 b, Wasserman, Comar and Tapper 1963); a similar effect, however, 
hus not been observed in humans (McKeill, Green and Rapoport 1962). 
The failure of the chelating EDTAto raise the urinary e~cretion (Fateyeva, 
Klimov, Ponizovskaya, Gorbarenlro; Sokolov and Smirnova 1960) is 
not surprising, due to the poor CO-ordinating properties of the alkali meta1 
ions. Continuous administration of the diuretic Diamox reduced the 
body burden of 13iCs in small rodents to approximately 70% of the control 
(Richmond and Furchner 1961 a); however, in humans dillretics proved 
to be ineffective (Rosoff, Cohn and Spencer 1963). A detailed enumera- 
tion of all other pharmaceuticals, hormodes, etc., which have been tested 
without positive results, cail be omitted. 
d promising approach is offered by the fact that the f&cal escretion 
of 13'Cs is rather lorv (Noslialev 1961 a) despite its fairly high secretion 
into the intestinal tract (Moore and Coinar 1962). , Obviously, a reabsorp- 
tion of 13iCs has to be assumed and i t  could be anticipated that an 
interruption of this ' enteral cycle ' mould raise tlie faecal escrction of 
13iCs. In Iieeping with this assiimptioil, Xraz and Patrick (1957 b) have 
demonstrated a distinct effect in animals rnaintaiiied on a diet containing 
bentonite or veriniculite: uith orally and paienterally admiiiistered 13'Cs, 
the body-burden was reduced to 70 and 80% of the control value, respec- 
tively. The iiet effect, though interesting from the theroretical riem- 
point, is disappointingly sxnall, and i t  is qiiestioilable wlietlier tlie 
cornpounds referred to above are the optimal ones. Summing up, i t  
can be stated that, so far, no antidotes are arailable for the treatmetit of 
internal contamination mith 13'Cs. 
The main accent of the preseiit inrestigation lies on the search for agents 
able to bind effectively 137Cs in the intestines and, in particular, on the 
elucidatiori of the efficacy pattern of ferric ferrocyanide, a compound 
which iri preliminary screening tests yielded rather pronlising results 
(NigroviC 1963). 
5 2. MATERIAL ARI) METHODS 
Carrier-free 13iCsC1 ( 2  pc; pH 2 .5)  was administered to albino rats of 
both seses either by gastric intubatiori or by intraperitoneal injectioil. 
The animals, 12 to 20 weeks old, were fasted for 20 hours prior to tlie oral 
administration. If iiot stated otherwise, the diet consisted of standard 
pellets (1 jo potassiuin) and water ad libitum. The retention of 13'Cs 
was followed by wliole-body couriting: a plastic sciiitillator ( T  in. diam., 
5 in. deep) was used. The activity, which was measiired immediately 
after tlie administration of 13;Cs, was taben as 1000,{,. Coiistarit counting 
efficiency was assured by assaying standard 137Cs-sainples. Screening 
experiments demoristrated t,hat the position of the rat in the plastic 
tube ( G  cm diam., 17.5 cm long, wall-t'liickness 0.5 cm) used did not 
irifluenee the counting rate. The tube-to-scintillator distance was 19 cm. 
All chemicals used were of analytical grade. The different insoluble 
metal salts of ferrocyaiiic acid were prepared by addition of the corres- 
ponding metal salt to potassiuin ferrocyanide solution in the appropriate 
molar amounts. The precipit'ates were separated by centrifugation, 
washed witli distilled water, dried and pulverizecl. 
The 137Cs-content of the body was expressed either as percentages of 
tlie administered 137Cs-amount, or as percentages of tlie coiitrol, i.e., tlie 
13iCs-conteiit of untreated animals; each single experimental series 
coiitained its o~vn control group. The number of rats per experimental 
group varied froin G to 10. 
s 3. R E S ~ L T S  
The first esperiments were designed to find tlie compounds with the 
greatest ability to bind 13'Cs in the intestinal tract, either by precipita- 
tion, absorption, or by ion-exchange. Carrier-free 137Cs and, immediately 
thereafter, the compound to be tested were administered by gastric tube. 
Sodium perchlorate, sodium-potassiuiii tartratc, sodiurn cobaltiriitrite, 
zirconium phospliate, magnesiuni tiisilicate, alumiiiium oxide, Graham's 
salt, Don~ex A, and polyacrilic acid, had no significant effect on the 
ahsorptioii of 13'Cs, and a detailed presentatiori of the resiilts is omitted. 
It may be mentioried only that the ability of Dowex A to bind I3'Cs 
in vitro proved to be high. so that oiie may assume that tlie bindiiig is 
not stable enough in vivo, when the presence of riunierous corii1)eting ions 
in the intestinal tract has to be taken into accourit. 
Bs can be seen from table I ,  sodium tetrapheiiylborate defiiiitrly 
reduces tJhe absorptjon of I3'Cs. In ordm to be effective this conlpound 
must be administered a t  the same time as the 13'Cs. Tlie efficacy is 
reduced when the administratiori was postponed even for 30 secorids 
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(experiment B, table I ) ,  becoming virtually negligible a t  greater intervals 
(data not presented). 
Table 1. Influence of orally administered sodium tetraphenylborate 
(TPB) on the enteral absorptioii of 13iCs. TPB was administered 
eitlier simultarieously with l3'Cs (experiment A) or approximately 
30 sec after the oral application of I3'Cs (experiment B). 
Fig. 1 summarizes the results of the esperiments n-here oral or intra- 
peritoneal adniinistratioii of 13'Cs V-as follo~ved after different tiine 
intervals by oral adinini~trat~ioii of ferric ferrocpriide (Priissian Blue, 
PB). TTith orally admiiiistered 13'Cs, there is a sharp dirninut,ioii of 
effectireness duriiig the first t1i70 hours, whereas n-it'h iiitra,peritoneally 
injected 13'Cs the time-dependeilce is less proiiounced. Obviously, the 
efficacy of PB admiiiistered after tliree hours does not depend upoil the 
lnode of administration of 13'Cs; in both cases, tlie body-burdeii is reduced 
to betnreen 80 and 907; of the control. 
Fig. 2 compares tlie effectiveness of PB and of the watei-soliible 
potassium ferrocyaiiide a t  different dose-lerels. Potassium ferrocyaiiide, 
though effectire in lo~ireririg tlie absorption of I3iCs, is defiiiitely inferior 
to PB. 
On the other hand, potassiuin ferrocynnide (10 nig!aiiinial) iiijected 
intraveiiously and simultaneously with 13'Cs, leads to a diniinislied 
elimination of I3'Cs; the body-burdeii oii the 7th da? beirig 70.5 5 1.570 
as compared witli 49.0 5 1.5'$/, in the corit,rol group. 
As can be seen from table 2 ,  there is iio sigiiificaiit differeiice bet,weeii 
tlie efficacy of 1'B prepared frorn sodiuiii aiid froin potassiuni ferro- 
cyanide. Separate administration of FeCI, aiid potassiiiiii ferrocyaiiide 
(ir i  a riiolar ratio of 3 : 3), n-liich shoilld be follon-ed by tlie precipitat'ion 
of P B  in the st'oiiiacli, is defiiiitely less effective tliaii PB. B reduced 
effectiveness was also observed for the other rnet,al salts of ferrocyaiiic 
seid enumerated iii table 2, as ~vell as for isotopical1~- diluted I3:Cs (table 3).  
mg TPB 
per rat 
Body-biirden (Oj, of dose and 
fiducial limits (P=O.O5) ) on tiie 
4th day 
erp. A 1 exp. B I 
A further experimental series tested the effect of continuously admini- 
stered PB on the retention of intraperitoneally injected 13'Cs. As can be 
Seen from fig. 3, an essentially lower body-burden results from PB mixed 
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137 . Cs ora l ly  
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Fig. 1. Influence of 50 mg Prussian Blue (PB) administered orally after 
different time intervals on the body-burden of orally and intra- 
peritoneally administered 13'Cs (on tlie 4th day). The vertical bars 
indicate fiducial limits (P=0.05). 
Table 2. Influence of Prussian Blue (PB) prepared either from potassium- 
or sodium-ferrocyanide, and other meta1 salts of ferrocyanic acid 
(CF) on the enteral absorption of orally administered 137Cs. 50 mg 








Body biirden (% of control 
and fiducial limits (P=O.O5) ) 
1.0 (0.6- 1.6) 
1.4 (1.1- 1.7) 
4.9 (2.3-10.3) 
S.2 (3.0-17.2) 
2.4 (1.2- 5.1) 
48.0 (23-101) 
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in drinking water) is, in accordance with the results presented in fig. 1, 
less effective. The poor effectiveness of the t ~ v o  highest dose-levels may 
be ascribed to the significantly reduced consumption of water by the rats. 
Also, a marked loss of body weight was noted in these groups. 
The relatively long duration of the PB-experiment (i.e., 17 days) makes 
it possible to determine the influence of PB on the retention function of 
Fig. 2. Iduence of different doses of potassium ferrocyanide (PFC) and 
Prussian Blue (PB) on the body-burden of 13'Cs (on t,he 4th day). Both 
compounds were given orally immediately after oral administration of 
137Cs. The vertical bars indicate fiducial limit,s (P=0.05). 
13'Cs. I n  all the experimental groups the dependence of the body-burden 
( B )  upon time ( t ,  in days) can be fitted satisfactorily by the multiexponen- 
tial expression 
R=a, exp ( -  A,t)+a,exp ( -  X-t).  
In  untreated animals, a ,  equals 250,; of the administered 137Cs-amount and 
is excreted with a half-time of approximately 1 day, whereas the residual 
75% (U,) are eliminated with a half-time of 8.5 days. The administration 
of PB exerts, as can be Seen from fig. 4, a twofold influence: i t  decreases 
U ,  and increases A,. Tlie increase of PB-dosage, ho~vever, gires rise to a 
slight increase of efficacy only. 
Since no attempts were made in the preceding experiments to determine 
the consumption of food and, thus, the actual intake of PB, in anotlier 
experiment PB was given by gastric tube twice daily (9 a.m. and 5 p.m.). 
The treatment schedule was varied as indicated in fig. 5 .  The slope of 
the retention curves in all PB-treated groups is identical and independent 
of the time when treatment was started; after cessation of treatment the 
curres ran parallel wit,h the control. The retention in the control group 
10 
0 01 0.1 1 10 
concentration (%) - 
F I ~ .  3  Influerice of PB and potassiurn ferrocyanide (PFC) offered at varyiiig 
concentrations with food and drinlciiig water, rcspectively, on tlie body- 
burden of 13'Cs. Treat'ment was started iminediat'ely after the intra- 
peritoneal irijection of ] "Cs. 
can be described by R = 17 exp ( - 0.770t) + 83 esp ( - 0.OGGt). I n  thc 
group, where PB was admiiiistcred begiiining 1 day after 137Cs-administra- 
tion, the correspondiiig equation is R = 18exp ( - 0.770t) + 82exp ( - 0.141t). 
This is in contrast to the preceding experiment (fig. 4), ~vhicli 
demonstrated a significant decrease of U, under the influence of PB. 
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Fig. 4. Effect of different doses of PB on tlie miiltiexponeiitial reteiition 
fiinction of 13'Cls. For furtlier esplariations see test,. 
An essential prerequisite for obtainirig a inaximal effect iiiider clironic 
experimeiital conditions is tlie proper spaciiig of multiple closes of PB. 
As cari be seeii froiii fig. G the sanie total close is sigiiificaiitly niorc cffectire 
xvheii it is divided in t,wo ecjual doses separated 1üy :! to  4 lioiirs. 
Fiiially, i t  niay be stressed tliat in all esperiinents iio tosic side effects 
of PB were ~ioted.  Even coiitinued treatnieiit witli high dosages (50 mg 
twice daily for 1 I days) was weil tolerated, aiicl iio loss of bodj--\veight 
was observed. 
% 4. D I ~ C C S S I ~ S  
I t  lies beyoild tlic scope of tliis study to discuss iii detail tlie iiiechaiiisili 
by n-liich PB binds CS', aiid pertiiierit piiblicatioiis dealiiig with this 
questioii are referred to (Kyrsli and Zryagiiitsev 1058. l'uslikarer 
Slirylev aiid Bagretsov I!)GO: Rogiiisliiy, ?tIaliiiiiia, Taiiovsliij~. A41tsliuler 
aiid JIorokhorets i960). Siiice the cq-stnl lattice of 1'13 coiitaiiis 
coiisiclerable amouiits of'potassiuiii. ioii-escliaiige is niost likely inrolved*. 
This is coiii1)atible V-ith tlie fact tliat an iiicrease of' tlie C's-coticeiitrntioii, 
i.e.. isotopic dilutioii of Ix'Cs$ is follon-ed by a decrease of PB-efficacy (tablr 
3) .  Xlthough otlier ii~etal salts of ferrociyaiiic acid biiicl Cs-. probably. in tlie 
sailie n-ay as PB ,  tlie reasoii for their lo~ver efficacj- is not yet clear: tlirir 
solubilitics are distiiictly liigher thaii that of I'B (Taiiaiiayer, C;lilshliora 
aiid Seifer 103(i), but tliese differeiices are iiot proiiouiiced eiioiigli to  
play a sigiiificaiit role. 
r 7 l l ie  experinielital results arc coiisisteiit n-itli tlie liypotlicsis oiitliiied 
iii tlie iiit,roductioii, iianiely tha,t I'B biiids Cs* iii tlie gilt aiid, tlius, iiitei- 
rupts its ' enteral cycle '. ,-\ppareiitly. the preseiice of otlier catioiis iii 
the gastroiiitestiiial tract. e.g., Ka-. I<- or Ca2', as  ~ ~ c l l  as chaiigcs of tlie 
pH, do iiot intcrfere with this eEect. 
"Tlie Iiighly selective ioii escliaiige of Cs on ferrocyaiiides lins beeil substniiti- 
ated by Iioufim. Itais aud AIillioii (J. Iiiorg. K1ic1. Cliim. 1064, 26, 3111). 
The most likelg niechanism by which the water-solrible potassium 
ferrocyailide exerts its infiuence is tlie in situ formatioii of 1% (solubility 
product 10-40, Tananayev et al. 1056) and of otlier insoluble 
feriocyaiiides. Since the efficacy of potassiuni ferrocyanide does not 
days ---- 
Fit. 5 .  Influence of ord PB (50 mg) on tlie retention of intra~~critoncally 
injected I3'Cs. PB was giren tn-ice daily. The diiration of trcatment 
is indicated bg the arrows. 
reach that of PB even when FeCI, is admiilistered additionally, the 
in  sitz6 precipitated material may well liave a different particle size and 
contain absorbed material whicli is not present in the i r ~  vitro prepared 
compound. 
I n  untreated animals, approximately 20% of 13'Cs is excreted with a 
half-tiinc of 1 day and tlie residual 80% with a half-t'iine of S to 1 1  days; 
this is in accordance with the observations of Richmoiid and Furchiier 
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(1961 U and b). Provided tliat 1% is admii~istered early, i.e., during the 
first 24 hours, i t  exerts a definite effect on both coinponerits. Obviously, 
the Iiigh rate of l3'Cs secretiori into the intestines, observed by Moore 
and Comar (19G2) during the first hour, is of short duratiori only. JYlien 
treatrneiit ~ r ~ i t h  PB is started after a delay, orily the slow compartmeiit is 
iiifiuenced. 
Table 3. Influeiice of 50 mg Prussiail Blue adniinistered orally ori the 
enteral absorptioil of isotopically diluteci lX7Cs. PB was given 
iminediately after the oral application of 13'Cs. 
Fjg. G. I~iflucii~c of orally ;idiuiiiistered PI3 on tlie body Lurdcii of iiitra- 
~)eritorienlly iiijected 137C's 011 tllc 4th da?. 100 iilg inimedintely after 
' 3 i  ( 1 .  50 ing iiiiiiietliatcl>- niid no  iiig tifter 2 (B), 4 (C ' )  aiid 
S Iiours (D). 'i'lic~ rcrticnl I);LI.s iridicate ficiuc:i;il liinits (1'=0.03). 
Carrier 
(W Cs) 
,411 esseiitial fcatiire is tliat tlie effectil-eiicss of PB reniairis coristatit 
irrespectiw of the time nlieii treatiileiit is started. aiid thnt tlit iiet 
effect is 13roportioiial t o  tlie diiratioii of trcatinciit. l'iiis is ralicl. a t  least, 
for tlie first n-eeks follon-iiig iiicorl)orntioii of lK;Cs. 
;\laximal efficacy caii bc a<*hiereci oiily if an optimnl aiid c»u.ctn~t 
coiicentratioil of PR is inaiiitaiiicd iii tlie \vliolc iiitestiiial trnct. l'liis is 
Eody-burden (7; of control 
and fidiicial liri~its (P=0.05) ) 
ori tlic 4th da'- 
exemplified by tlie results sho~vri in fig. 6. For technical reasons (in 
the experiment where PB was given by gastric tube), and berause of the 
irregiilar coiisumption of food by the rats, there can be no doubt tliat the 
largest obtaiiiable effect was not achieved in oui experiments. In  spite 
of this, the actually observed effect, i.e., reductioii of the bodg-burclen 
by 80 to 85O/„ is fairlg high arid compares n-ell witli tlie results obtairied 
n-itli other iadioiliiclides by the use of specific cl-ielatiiig ageiits. 
In  rieu. of the high efficacy as well as the complete lacli of aiiy toxic 
side effects, PB miist be considered as a valuable antidote iri cases 
of accidental internal contamiiiation with 13iCs. -4s to tlie usage of I'B 
iri liumans, i t  cari bc reasonablg anticipated tliat it will exert a si~nilar 
effect to that seen in rats, if \Te are dealiiig with tlie ingestioa of 13'Cs. 
'Cl'hetlier this is valid for a purenteral coiitariiinatioii is not yet clear, siiice 
tlie enteral secretion rate in huniaiis is not get kiio~vn. ,41tliougli the 
ratio of faecal to urinary 13iCs-excretioii in huinans is, by aiid large, 
comparable to tlie iatio in rats (Rosoff et al .  1963, JIraz aiicl Patrick 
1957 a), the net excretion is clefiiiitely lower. Experiiiieilts aiming a t  the 
elucidation of tliis question as well as oii tlie elaboratiori of aii optiiiial 
dosage and treatriieiit sclietlule are iirgently rieeded. 
l\'e U-isli to thaiik Jliss H. Recliert aiid Miss I). Doiiiprobst for sliilfiil 
techriical assistailce. Sodiurn tetrapheriylborate (Kaligiiost) was obtaiiied 
by eourtesy of Heyc aild Co., Berlin-Steglik. 
Ttie c~ffcctiveiit:as of scveral coriipoiinds iri suppressirig tlie enteral alrsorptioii cif 13'Cs 
in rilti; was testcd. All agtxIits were fouiitl to  Lc iiirfft~rtive, n-itli tlie exceptioii ofso<liiim 
tetraplienylborate. potassiuin Eerroq-anitir arid, iii pnrticular, ferric ferroc.yanitle (I'riissian 
131ue). Tlie decreüse in entcrtil absorptioii of 13'Cs 1)'- oral ntlrriinistruti«ii of 1% 1s <lcl)critlent 
upon (lose and tiine of atlini~iistratioii. Tlie iriasiirial cftect nrliievetl is tlie reductiori of the  
body-t~urderi by  90°0. He~pr.atet1 oral atliiiinistratioii of I'L3 also riitiaiirc~s siil)st;~ritially 
the escretioii of pareritcrally administerctl '"Cs Tliis eftivt 1%-as fouiicl tu bc iridt~~>eritlciit 
on tlie time v,lien treatiiieiit was startrtl. S n  toxir sitle cfliacts of PB 1rci.t. ol>serretl. 
L'iriflucnce de Bleu tle I'russe r t  (l 'autrrs r«mpo,i.s sur la r6tcntion dc ruclio-c6siuin 
par le rat .  
Ori a ¿tudi¿. l'cffrcacit4 de plusieurs sulrstanres en r e  qui coticcriie 1s s u ~ ] w c w ~ ~ ) i i  (le 
I'absorption intestinale d u  '3'Cs cliez le rat .  L s  plupart des ageiits se soiit ri.vel&s incfiirnc.es 
& l'c,xception du t&traphenylt~orate de  sodiurn, tlu forrocyanute de potassii~in o t  en particulior 
d u  ferrrrcyanatc ferrique (PD). Le PB, ndministr6 pur voie orale, r6duit l'absorptioii iiites- 
tinale du  13'Cs en foriction de  lo, rlose e t  dii teinps. L'effot inasiirium obtenu a 6t6 iiiie 
r6durtiori de 09 pour cent de l'absorptiori. Des doses ropetees reduisent aussi coiisi<lGrnl>le- 
merit la retcntion du CS injecte Par voie parenterale. Cet effet ne  depend pus dc l'iritcr- 
valle de  teinps eiltrc l'irijection du 13'Cs c t  1e t r a i t e~ne~ i t .  I,e PB n'a preseiite nucuii ~ f f e t  
toxique secondaire. 
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Die Einwirliung vor1 Uerliiiorhlau und anderen Verbindungen auf die Retention von 
Radiozasium im Ratte:iliörper. 
E s  wurde der Eirifluss verschiedener Substanzen auf die enterale Resorption von 13:Cs 
bei der Rat te  untersucht. Alle Substanzen erwiesen sich als unmirksairi mit  Ausrtahme 
von Xntriuintetraphcr1~1br>rat, Iialiumcyanoferrut (11) uiid vor allem von Fcrrieyanoferrat 
( 1 1  ( B )  Die Heminurig der enteralen 137Cs-Resorption ciurch oral verabreichtes PB 
hangt von der Dosis und vom Zeitpunkt der Terabfolgurip ab .  J l a x i m l  wird eine Henimung 
um 99 Y/ ,  erreiclit. \Viederlioltr orale Verabfolgung von PB bewirkt ebenfalls eine erhebliche 
Beschleunigurig der Ausschridung von intraperitoneal injiziertem 'z7Cb, und war unab- 
liangig vom Zeitpunkt der Beliaiidluiig. 1'B erwies sich als nichttoxisch. 
Ilay~iaxoci, aefic~niie pnxa neruecTu Ha pe3op6uiiio 13'Cs 113 I<rmeqlrIiKa IIPLICLI. Rce 
neuIecTna oriasaniicr, i r e ~ ~ + e I t ~ i r ß t ~ ~ ~ . t ~ r r  aa ricx:iioueHricn ~e~pa+e111136opa~a rr ~prirr, 
+ e p p o i i r i a ~ ~ ~ ~ a  ItanIrrr 11, n oco6e~1rioc~1i, $eppouirarrii~a iiienesa (111) (PB;. PU rro~annrrx 
pesop6uriro ',':Cs n saniic~i.tioarr «T 203h1 ~i OT npearelrrr nExaeiirin. ~ U ~ I ( C I I . ~ I ~ X L I I O ~  
cari;iceriire pc3op61~riii cocTartn5ie.r 9 9 O „ .  1Toi:~opiroc opa;ibEioe uIleaeIIiie I'B Taic;i;e B 
311a.rrr~en~croii cTenetrrr ~ C I I C ) ~ I ~ C T  D L I B ~ J ~ I I I I ~  I J I ~ ~ : I ~ I I I ~ O I - O  napJriTepaxLIx0 'j7Cs.   TOT 
34@l~li~ 3 3 B i l C i I T  OT 13pCMellII t3ilC;ICIIIIR. PU Iie 13LI3LIßäCT ~ 1 0 6 0 ~ t I 1 ~ i ~  TOFiCZIrleCi<ii~ 
B + ( ~ ~ I < T O B .  
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